UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery

BMC cancer, 2020-07, Vol.20 (1), p.664-664, Article 664

2020

Volltextzugriff (PDF)

The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population

BMC cancer, 2019-01, Vol.19 (1), p.22-22, Article 22

2019

Volltextzugriff (PDF)

Prevalent distribution and survival outcome of HPV infection in patients with early-stage cervical cancer in Hangzhou, China

BMC infectious diseases, 2022-12, Vol.22 (1), p.941-941, Article 941

2022

Volltextzugriff (PDF)

Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?

Radiation oncology (London, England), 2022-10, Vol.17 (1), p.1-167, Article 167

2022

Volltextzugriff (PDF)

Prognostic factors affecting survival and recurrence in patients with early cervical squamous cell cancer following radical hysterectomy

Journal of international medical research, 2020-04, Vol.48 (4), p.300060519889741-300060519889741

2020

Volltextzugriff (PDF)

Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer

Radiation oncology (London, England), 2019-05, Vol.14 (1), p.82-9, Article 82

2019

Volltextzugriff (PDF)

Stromal score is a promising index in tumor patients’ outcome determination

Heliyon, 2023-11, Vol.9 (11), p.e22432-e22432, Article e22432

2023

Volltextzugriff (PDF)

Association of pretreatment SUVmax of cervix and SCC‐antigen with FIGO2018 stage in Stage IIB–IVB squamous cervical cancer and relationship to prognosis

International journal of gynecology and obstetrics, 2021-01, Vol.152 (1), p.112-117

2021

Volltextzugriff (PDF)

Genomic characterization of primary cervical cancer and lung metastasis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17527-e17527

2022

Volltextzugriff (PDF)

Association of pretreatment SUV max of cervix and SCC-antigen with FIGO2018 stage in Stage IIB-IVB squamous cervical cancer and relationship to prognosis

International journal of gynecology and obstetrics, 2021-01, Vol.152 (1), p.112-117

2021

Volltextzugriff (PDF)

Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I-IIB

Medicine (Baltimore), 2018-01, Vol.97 (2), p.e9323-e9323

2018

Volltextzugriff (PDF)

Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study

Clinical cancer research, 2024-04, Vol.30 (8), p.1501

2024

Volltextzugriff (PDF)

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

The lancet oncology, 2023-10, Vol.24 (10), p.1134-1146

2023

Volltextzugriff (PDF)

Immune Response of Plasmacytoid Dendritic Cells Stimulated by Human Papillomavirus (HPV) E6 in an In Vitro System

Medical science monitor, 2020-02, Vol.26, p.e919770-e919770

2020

Volltextzugriff (PDF)

SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study

Clinical cancer research, 2022-12, Vol.28 (24), p.5297-5305

2022

Volltextzugriff (PDF)

HPV‐related cervical diseases: Alteration of vaginal microbiotas and promising potential for diagnosis

Journal of medical virology, 2023-01, Vol.95 (1), p.e28351-n/a

2023

Volltextzugriff (PDF)

Application of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Acute Rectal Injury: A Multicenter, Randomized, Open-label, Prospective Trial

International journal of radiation oncology, biology, physics, 2024-05

2024

Volltextzugriff (PDF)

Application of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Acute Rectal Injury: A Multi-center, Randomized, Open-label, Prospective Trial

International journal of radiation oncology, biology, physics, 2024-05

2024

Volltextzugriff (PDF)

A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.106-106

2022

Volltextzugriff (PDF)

Efficacy and safety of cisplatin combined with paclitaxel concurrent radiotherapy in patients with locally advanced cervical squamous cell carcinoma

Journal of gynecologic oncology, 2024, Vol.36

2024

Volltextzugriff (PDF)

Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma

International journal of gynecological cancer, 2017-11, Vol.27 (9), p.1919-1925

2017

Volltextzugriff (PDF)

Efficacy and safety of cadonilimab, an anti-PD-1/CTLA4 bi-specific antibody, in previously treated recurrent or metastatic (R/M) cervical cancer: a multicenter, open-label, single-arm, phase II trial (075)

Gynecologic oncology, 2022-08, Vol.166, p.S47-S48

2022

Volltextzugriff (PDF)

251 Efficacy and safety of iparomlimab and tuvonralimab in previously treated patients with recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase 2 clinical trial (DUBHE-C-206)

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A5-A5

2024

Volltextzugriff (PDF)

Increased frequency of regulatory T cells in the peripheral blood of patients with endometrioid adenocarcinoma

Oncology letters, 2019-08, Vol.18 (2), p.1424-1430

2019

Volltextzugriff (PDF)

Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer

Cancer management and research, 2019-08, Vol.11, p.7759-7766

2019

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)
Buchkapitel
(1)

Sprache

Englisch
(26)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Female
(11)
Humans
(11)
Cervical Cancer
(10)
Oncology
(9)
Prognosis
(8)
Chemotherapy
(6)
Lymphatic System
(6)
Medical Prognosis
(6)
Metastasis
(6)
Survival
(6)
Cancer
(5)
Cancer Therapies
(5)
Neoplasm Staging
(5)
Radiotherapy
(5)
Retrospective Studies
(5)
Tumors
(5)
Uterine Cervical Neoplasms - Pathology
(5)
Cancer Metastasis
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery

The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population

Prevalent distribution and survival outcome of HPV infection in patients with early-stage cervical cancer in Hangzhou, China

Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?

Prognostic factors affecting survival and recurrence in patients with early cervical squamous cell cancer following radical hysterectomy

Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer

Stromal score is a promising index in tumor patients’ outcome determination

Association of pretreatment SUVmax of cervix and SCC‐antigen with FIGO2018 stage in Stage IIB–IVB squamous cervical cancer and relationship to prognosis

Genomic characterization of primary cervical cancer and lung metastasis

Association of pretreatment SUV max of cervix and SCC-antigen with FIGO2018 stage in Stage IIB-IVB squamous cervical cancer and relationship to prognosis

Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I-IIB

Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Immune Response of Plasmacytoid Dendritic Cells Stimulated by Human Papillomavirus (HPV) E6 in an In Vitro System

SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study

HPV‐related cervical diseases: Alteration of vaginal microbiotas and promising potential for diagnosis

Application of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Acute Rectal Injury: A Multicenter, Randomized, Open-label, Prospective Trial

Application of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Acute Rectal Injury: A Multi-center, Randomized, Open-label, Prospective Trial

A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC)

Efficacy and safety of cisplatin combined with paclitaxel concurrent radiotherapy in patients with locally advanced cervical squamous cell carcinoma

Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma

Efficacy and safety of cadonilimab, an anti-PD-1/CTLA4 bi-specific antibody, in previously treated recurrent or metastatic (R/M) cervical cancer: a multicenter, open-label, single-arm, phase II trial (075)

251 Efficacy and safety of iparomlimab and tuvonralimab in previously treated patients with recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase 2 clinical trial (DUBHE-C-206)

Increased frequency of regulatory T cells in the peripheral blood of patients with endometrioid adenocarcinoma

Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer

Suchergebnisse filtern